Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merit Cudkowicz

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 8, 2026
ALS untangled #83: clenbuterolAdam Burgess, Olivia Allen, Paul Barkhaus, et al.
Neurology Open Access|July 8, 2025
A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH TrialKa-Ho Wong, Gregory Scott Day, James C Torner, et al.
Annals of Neurology|November 20, 2018
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic StrokePatrick Lyden, Kent E Pryor, Christopher S Coffey, et al.
Neurology|October 4, 2019
Prospective natural history study of <i>C9orf72</i> ALS clinical characteristics and biomarkersAlexander J Cammack, Nazem Atassi, Theodore Hyman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 6, 2025
ENLITE PD: A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's DiseaseAleksandar Videnovic, Christopher S Coffey, Elizabeth B Klerman, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 19, 2021
Preface: promoting research in PLS: current knowledge and future challengesHiroshi Mitsumoto, Martin R Turner, , et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
JAMA Neurology|March 24, 2020
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical TrialsMerit Cudkowicz, Marianne K Chase, Christopher S Coffey, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 8, 2026
ALS untangled #83: clenbuterolAdam Burgess, Olivia Allen, Paul Barkhaus, et al.
Neurology Open Access|July 8, 2025
A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH TrialKa-Ho Wong, Gregory Scott Day, James C Torner, et al.
Annals of Neurology|November 20, 2018
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic StrokePatrick Lyden, Kent E Pryor, Christopher S Coffey, et al.
Neurology|October 4, 2019
Prospective natural history study of <i>C9orf72</i> ALS clinical characteristics and biomarkersAlexander J Cammack, Nazem Atassi, Theodore Hyman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 6, 2025
ENLITE PD: A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's DiseaseAleksandar Videnovic, Christopher S Coffey, Elizabeth B Klerman, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 19, 2021
Preface: promoting research in PLS: current knowledge and future challengesHiroshi Mitsumoto, Martin R Turner, , et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
JAMA Neurology|March 24, 2020
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical TrialsMerit Cudkowicz, Marianne K Chase, Christopher S Coffey, et al.
Pageof 12